Literature DB >> 26276768

Acute leukemias of ambiguous origin.

Anna Porwit1, Marie C Béné2.   

Abstract

OBJECTIVES: This session of the Society for Hematopathology/European Association for Haematopathology Workshop focused on acute leukemias of ambiguous origin.
METHODS: We provide an overview of mixed-phenotype acute leukemia (MPAL) as recognized in the current World Health Organization classification and summarize diagnostic criteria for major categories of MPAL: B/myeloid, T/myeloid, B/T, and B/T/myeloid.
RESULTS: Most MPAL cases submitted were B/myeloid and T/myeloid MPAL, the most frequent types, but three cases of B/T MPAL were also submitted, and examples of all categories are illustrated. We emphasize that a comprehensive approach to immunophenotyping is required to accurately establish the diagnosis of MPAL. Flow cytometry immunophenotyping using a large panel of antibodies is needed as well as confirmatory immunohistochemical analysis and cytochemistry studies for myeloperoxidase and nonspecific esterase. We discuss technical issues in determining blast lineage and possible pitfalls in MPAL diagnosis. In particular, rare cases of B-acute lymphoblastic leukemia (B-ALL) can express myeloperoxidase but are otherwise consistent with B-ALL and should be treated as such. Last, we review the differential diagnosis between acute undifferentiated leukemia and acute myeloid leukemia with minimal differentiation.
CONCLUSIONS: There was an agreement that diagnosis of MPAL can be challenging, especially if applied flow cytometry panels are not comprehensive enough. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Acute leukemia; Immunophenotype; Lineage; Lymphoid; Mixed phenotype acute leukemia; Myeloid; Undifferentiated acute leukemia

Mesh:

Year:  2015        PMID: 26276768     DOI: 10.1309/AJCPSTU55DRQEGTE

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation.

Authors:  Wenbin Xiao; Maheetha Bharadwaj; Max Levine; Noushin Farnhoud; Friederike Pastore; Bartlomiej M Getta; Anne Hultquist; Christopher Famulare; Juan S Medina; Minal A Patel; Qi Gao; Natasha Lewis; Janine Pichardo; Jeeyeon Baik; Brian Shaffer; Sergio Giralt; Raajit Rampal; Sean Devlin; Robert Cimera; Yanming Zhang; Maria E Arcila; Elli Papaemmanuil; Ross L Levine; Mikhail Roshal
Journal:  Blood Adv       Date:  2018-12-11

2.  Mutational and transcriptomic profiling of acute leukemia of ambiguous lineage reveals obscure but clinically important lineage bias.

Authors:  Zhen-Tang Lao; Ling-Wen Ding; Omer An; Norimichi Hattori; Qiao-Yang Sun; Kar-Tong Tan; Anand Mayakonda; Wong Gee Chuan; Vikas Madan; De-Chen Lin; Henry Yang; H Phillip Koeffler
Journal:  Haematologica       Date:  2018-12-04       Impact factor: 9.941

3.  Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia.

Authors:  Bartlomiej M Getta; Mikhail Roshal; Junting Zheng; Jae H Park; Eytan M Stein; Ross Levine; Esperanza B Papadopoulos; Ann A Jakubowski; Nancy A Kernan; Peter Steinherz; Richard J O'Reilly; Miguel-Angel Perales; Sergio A Giralt; Martin S Tallman; Brian C Shaffer
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-08       Impact factor: 5.742

Review 4.  Recent advances and novel treatment paradigms in acute lymphocytic leukemia.

Authors:  Nikolaos Papadantonakis; Anjali S Advani
Journal:  Ther Adv Hematol       Date:  2016-06-29

5.  Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia.

Authors:  Aparna Pallavajjala; Daehwan Kim; Tongbin Li; Gabriel Ghiaur; Richard J Jones; Kathleen H Burns; Steven L Salzberg; Yi Ning
Journal:  Leuk Lymphoma       Date:  2017-09-07

6.  Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells.

Authors:  Claudia C Roskopf; Todd A Braciak; Nadja C Fenn; Sebastian Kobold; Georg H Fey; Karl-Peter Hopfner; Fuat S Oduncu
Journal:  Oncotarget       Date:  2016-04-19

7.  Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing.

Authors:  Andrés E Quesada; Zhihong Hu; Mark J Routbort; Keyur P Patel; Rajyalakshmi Luthra; Sanam Loghavi; Zhuang Zuo; C Cameron Yin; Rashmi Kanagal-Shamanna; Sa A Wang; Jeffrey L Jorgensen; L Jeffrey Medeiros; Chi Young Ok
Journal:  Oncotarget       Date:  2018-01-03

Review 8.  Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies.

Authors:  Chun-Fung Sin; Pui-Hei Marcus Man
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

9.  LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL.

Authors:  Xuanmei Huang; Libin Huang; Qing Xie; Ling Zhang; Shaohui Huang; Mingye Hong; Jiangbin Li; Zunnan Huang; Hua Zhang
Journal:  Biomark Res       Date:  2021-06-10

10.  IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML.

Authors:  Belen Lopez-Millan; Rafael Diaz de la Guardia; Heleia Roca-Ho; Eduardo Anguita; Abul B M M K Islam; Damia Romero-Moya; Cristina Prieto; Francisco Gutierrez-Agüera; Jose Antonio Bejarano-Garcia; Jose Antonio Perez-Simon; Paula Costales; Montse Rovira; Pedro Marín; Silvia Menendez; Mar Iglesias; Jose Luis Fuster; Alvaro Urbano-Ispizua; Fernando Anjos-Afonso; Clara Bueno; Pablo Menendez
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.